These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 28459433)

  • 61. Epigenetic and metabolic programming of innate immunity in sepsis.
    Vachharajani V; McCall CE
    Innate Immun; 2019 Jul; 25(5):267-279. PubMed ID: 30997862
    [TBL] [Abstract][Full Text] [Related]  

  • 62. TRAINED IMMUNITY: A POTENTIAL APPROACH FOR IMPROVING HOST IMMUNITY IN NEONATAL SEPSIS.
    Polcz VE; Rincon JC; Hawkins RB; Barrios EL; Efron PA; Moldawer LL; Larson SD
    Shock; 2023 Feb; 59(2):125-134. PubMed ID: 36383390
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunometabolic approaches to prevent, detect, and treat neonatal sepsis.
    Conti MG; Angelidou A; Diray-Arce J; Smolen KK; Lasky-Su J; De Curtis M; Levy O
    Pediatr Res; 2020 Jan; 87(2):399-405. PubMed ID: 31689710
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Influence of innate immune activation on endocrine and metabolic pathways in infancy.
    O'Connor KM; Ashoori M; Dias ML; Dempsey EM; O'Halloran KD; McDonald FB
    Am J Physiol Endocrinol Metab; 2021 Jul; 321(1):E24-E46. PubMed ID: 33900849
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An Immunological Perspective on Neonatal Sepsis.
    Kan B; Razzaghian HR; Lavoie PM
    Trends Mol Med; 2016 Apr; 22(4):290-302. PubMed ID: 26993220
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Altered Cellular Metabolism Drives Trained Immunity.
    Sohrabi Y; Godfrey R; Findeisen HM
    Trends Endocrinol Metab; 2018 Sep; 29(9):602-605. PubMed ID: 29627292
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Application of Monte Carlo cross-validation to identify pathway cross-talk in neonatal sepsis.
    Zhang Y; Liu C; Wang J; Li X
    Exp Biol Med (Maywood); 2018 Mar; 243(5):444-450. PubMed ID: 29513099
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunological Defects in Neonatal Sepsis and Potential Therapeutic Approaches.
    Raymond SL; Stortz JA; Mira JC; Larson SD; Wynn JL; Moldawer LL
    Front Pediatr; 2017; 5():14. PubMed ID: 28224121
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Targeting neutrophil: new approach against hypertensive cardiac remodeling?
    Obama T; Scalia R; Eguchi S
    Hypertension; 2014 Jun; 63(6):1171-2. PubMed ID: 24711521
    [No Abstract]   [Full Text] [Related]  

  • 70. Expansion of activated regulatory T cells inversely correlates with clinical severity in septic neonates.
    Timperi E; Folgori L; Amodio D; De Luca M; Chiurchiù S; Piconese S; Di Cesare S; Pacella I; Martire C; Bonatti G; Perrone S; Boni T; Marcovecchio GE; Reale A; Parisi F; Dotta A; Barnaba V; Rossi P
    J Allergy Clin Immunol; 2016 May; 137(5):1617-1620.e6. PubMed ID: 26792206
    [No Abstract]   [Full Text] [Related]  

  • 71. Is programming of weight regulation immune to neonatal inflammation?
    Luheshi GN; Rummel C
    Am J Physiol Regul Integr Comp Physiol; 2007 Aug; 293(2):R578-80. PubMed ID: 17537838
    [No Abstract]   [Full Text] [Related]  

  • 72. Corrigendum: S100-alarmin-induced innate immune programming protects newborn infants from sepsis.
    Ulas T; Pirr S; Fehlhaber B; Bickes MS; Loof TG; Vogl T; Mellinger L; Heinemann AS; Burgmann J; Schöning J; Schreek S; Pfeifer S; Reuner F; Völlger L; Stanulla M; von Köckritz-Blickwede M; Glander S; Barczyk-Kahlert K; von Kaisenberg CS; Friesenhagen J; Fischer-Riepe L; Zenker S; Schultze JL; Roth J; Viemann D
    Nat Immunol; 2017 Sep; 18(10):1173. PubMed ID: 28926540
    [No Abstract]   [Full Text] [Related]  

  • 73. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages.
    Ip WKE; Hoshi N; Shouval DS; Snapper S; Medzhitov R
    Science; 2017 May; 356(6337):513-519. PubMed ID: 28473584
    [TBL] [Abstract][Full Text] [Related]  

  • 74. S100-alarmins: potential therapeutic targets for arthritis.
    Austermann J; Zenker S; Roth J
    Expert Opin Ther Targets; 2017 Jul; 21(7):739-751. PubMed ID: 28494625
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation.
    He YM; Li X; Perego M; Nefedova Y; Kossenkov AV; Jensen EA; Kagan V; Liu YF; Fu SY; Ye QJ; Zhou YH; Wei L; Gabrilovich DI; Zhou J
    Nat Med; 2018 Feb; 24(2):224-231. PubMed ID: 29334374
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cellular Differentiation of Human Monocytes Is Regulated by Time-Dependent Interleukin-4 Signaling and the Transcriptional Regulator NCOR2.
    Sander J; Schmidt SV; Cirovic B; McGovern N; Papantonopoulou O; Hardt AL; Aschenbrenner AC; Kreer C; Quast T; Xu AM; Schmidleithner LM; Theis H; Thi Huong LD; Sumatoh HRB; Lauterbach MAR; Schulte-Schrepping J; Günther P; Xue J; Baßler K; Ulas T; Klee K; Katzmarski N; Herresthal S; Krebs W; Martin B; Latz E; Händler K; Kraut M; Kolanus W; Beyer M; Falk CS; Wiegmann B; Burgdorf S; Melosh NA; Newell EW; Ginhoux F; Schlitzer A; Schultze JL
    Immunity; 2017 Dec; 47(6):1051-1066.e12. PubMed ID: 29262348
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Brown-adipose-tissue macrophages control tissue innervation and homeostatic energy expenditure.
    Wolf Y; Boura-Halfon S; Cortese N; Haimon Z; Sar Shalom H; Kuperman Y; Kalchenko V; Brandis A; David E; Segal-Hayoun Y; Chappell-Maor L; Yaron A; Jung S
    Nat Immunol; 2017 Jun; 18(6):665-674. PubMed ID: 28459435
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells.
    Bosurgi L; Cao YG; Cabeza-Cabrerizo M; Tucci A; Hughes LD; Kong Y; Weinstein JS; Licona-Limon P; Schmid ET; Pelorosso F; Gagliani N; Craft JE; Flavell RA; Ghosh S; Rothlin CV
    Science; 2017 Jun; 356(6342):1072-1076. PubMed ID: 28495875
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A guiding map for inflammation.
    Netea MG; Balkwill F; Chonchol M; Cominelli F; Donath MY; Giamarellos-Bourboulis EJ; Golenbock D; Gresnigt MS; Heneka MT; Hoffman HM; Hotchkiss R; Joosten LAB; Kastner DL; Korte M; Latz E; Libby P; Mandrup-Poulsen T; Mantovani A; Mills KHG; Nowak KL; O'Neill LA; Pickkers P; van der Poll T; Ridker PM; Schalkwijk J; Schwartz DA; Siegmund B; Steer CJ; Tilg H; van der Meer JWM; van de Veerdonk FL; Dinarello CA
    Nat Immunol; 2017 Jul; 18(8):826-831. PubMed ID: 28722720
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.